🇺🇸 FDA
Pipeline program

Palmidrol

ACCRU-SC-2102

Phase 2 small_molecule active

Quick answer

Palmidrol for Chemotherapy-Induced Peripheral Neuropathy is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chemotherapy-Induced Peripheral Neuropathy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials